Navigation Links
Epizyme, Inc. to Present at Upcoming Conferences in September
Date:8/28/2013

CAMBRIDGE, Mass., Aug. 28, 2013 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in upcoming September conferences.

  • Citi 8th Annual Biotech Day at the Mandarin Oriental Hotel in Boston, Mass. on Wednesday, September 4th
  • JMP Securities Biotech Day at the Langham Hotel in Boston, Mass. on Friday, September 6th at 11:00 a.m. ET.
  • Morgan Stanley Global Healthcare Conference at the Grand Hyatt in New York, N.Y. on Wednesday, September 11th at 8:00 a.m. ET. A live webcast will be available at this link or by visiting the Investor Center of the Epizyme website at www.epizyme.com. An archived replay of the webcast will be available on the Company's website for 30 days after the conference.
  • Stifel Nicolaus Healthcare Conference 2013 at the Four Seasons Hotel in Boston, Mass. on Thursday, September 12th at 2:05 p.m. ET. A live webcast will be available at this link or by visiting the Investor Center of the Epizyme website at www.epizyme.com. An archived replay of the webcast will be available on the Company's website for 30 days after the conference.
  • BioPharm America Conference at the Westin Boston Waterfront in Boston, Mass. on Tuesday, September 17th at 2:45 p.m. ET in a panel discussion titled "Partnering: Thinking beyond the deal."
  • Cancer Advance Boston at the Harvard Medical School in Boston, Mass. on Thursday, September 19th at 3:00 p.m. ET in a panel discussion titled "Redefining Cancer: Insights from Cancer Stem Cells, Epigenetics, Immunotherapy and More."
  • LES Annual Meeting at the Philadelphia Marriott Downtown in Philadelphia, Pa. on Monday, September 23rd at 12:15 p.m. ET to receive the 2013 LES Deal of Distinction Award in the Life Sciences Sector.
  • Discovery On Target 2013 at the Westin Boston Waterfront in Boston, Mass. on Tuesday, September 24th at 11:45 a.m. ET, presenting on targeting histone methyltransferases in cancer therapy.
  • BioCentury's NewsMakers in the Biotech Industry Conference at the Millennium Broadway Hotel & Conference Center in New York, N.Y. on Friday, September 27th at 9:00 a.m. ET. A live webcast will be available at this link or by visiting the Investor Center of the Epizyme website at www.epizyme.com. An archived replay of the webcast will be available on the Company's website for 30 days after the conference.

About Epizyme, Inc.
Epizyme, Inc. is a clinical stage biopharmaceutical company creating personalized therapeutics for patients with genetically defined cancers. Epizyme has built a proprietary product platform that the company uses to create small molecule inhibitors of a 96-member class of enzymes known as histone methyltransferases, or HMTs. HMTs are part of the system of gene regulation, referred to as epigenetics, that controls gene expression. Genetic alterations can result in changes to the activity of HMTs, making them oncogenic (cancer-causing). By focusing on the genetic drivers of cancers, Epizyme's targeted science seeks to match the right medicines with the right patients for a personalized approach to cancer treatment.

For more information, visit http://www.epizyme.com and connect with us on Twitter at @EpizymeRx.


'/>"/>
SOURCE Epizyme, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Epizyme, Inc. to Present at Wedbush Securities Life Sciences Management Access Conference in August
2. Epizyme, Inc. to Webcast Conference Call Discussing Second Quarter 2013 Financial Results on July 31, 2013
3. Epizyme, Inc. Announces Pricing of Initial Public Offering
4. Epizyme, Inc. Files Registration Statement for Proposed Initial Public Offering
5. Genocea Biosciences Selected To Present Late-Breaking Oral Presentation At ICAAC 2013
6. BioLineRx to Present at 15th International Celiac Disease Symposium
7. BioLineRx to Present at 2013 Stifel Nicolaus Healthcare Conference In Boston
8. Affordable IVF Presents A Free Information Evening
9. Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
10. Thoratec Presentation At Morgan Stanley 2013 Health Care Conference To Be Webcast
11. Zimmer Holdings to Present at UBS Best of Americas Conference 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
Breaking Medicine News(10 mins):